A seven-year medical research study reported that women whose mothers took the drug DES during pregnancy were twice as likely to develop tissue abnormalities that might lead to cancer as were women whose mothers did not take the drug. a. This study compared two populations. What were the populations? b. Do you suppose the data were obtained in a survey or an experiment? c. For the population of women whose mothers took the drug DES during pregnancy, a sample of 3980 women showed that 63 developed tissue abnormalities that might lead to cancer. Provide a descriptive statistic that could be used to estimate the number of women out of 1000 in this population who have tissue abnormalities.

The classification of the set of circumstances is presented in the following subsections of the understanding.

Step-by-step explanation:

A 7-year health research project revealed that individuals for whom the mom took DES throughout pregnancy seem to have been twice as probable as women for whom the mothers didn't use the medication to establish tissue irregularities that could cause cancer.  

(a)

Women with whom the mothers have taken DES throughout pregnancy as well as women where its mothers haven't taken DES during pregnancy.

(b)

The information collected seems to have been a sample or survey.  

(c)

A sampling unit of 3980 (women) showed that performance 63 industrialized tissue irregularities that could contribute to disease (cancer) in the proportion of females with whom the mom brought the powerful DES all through pregnancy.  

The proportion of abnormalities in tissues established by females does seem to be:  

=  

=  

Of every thousand women, 15.8 established tissue abnormalities.